Company:  DARE BIOSCIENCE, INC. (DARE)
Form Type:  DEF 14A
Filing Date:  5/31/2018 
CIK:  0001401914 
Address:  3655 NOBEL DRIVE
SUITE 260
 
City, State, Zip:  SAN DIEGO, California 92122 
Telephone:  858-926-7655 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$1.02  
Change: 
0.025 (2.53%)  
Trade Time: 
04:00 PM EST  
Market Cap: 
$11.59M
Trade DARE now with 

© 2018  
Description of Business
The terms "we," "us," "our," "Daré" or the "Company" refer collectively to Daré Bioscience, Inc. and its wholly-owned subsidiaries, unless otherwise stated or the context otherwise requires. All information presented in this report is based on our fiscal year. Unless otherwise stated, references to particular years, quarters, months or periods refer to our fiscal years ending December 31 and the associated quarters, months and periods of those fiscal years. Overview We are a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women's reproductive health. We are driven by a mission to identify, develop and bring to market a diverse portfolio of differentiated therapies that expand treatment options, improve outcomes and facilitate convenience for women, primarily in the areas of contraception, vaginal health, sexual health and fertility.
Register and access this filing in:     
  FORM DEF 14A
    NOTICE OF ANNUAL MEETING OF STOCKHOLDERS
      INCOME STATEMENT
    PROXY STATEMENT
      NAME AND TITLE
    Director Compensation
    Audit Committee Report *
      NAME AND TITLE
    EXECUTIVE COMPENSATION
      COMPENSATION TABLE
      OPTIONS AGGREGATE
    SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
      BENEFICIAL OWNERS
    CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
    PROPOSAL 1
    PROPOSAL 2
    PROPOSAL 3
    OTHER MATTERS
    THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED.